0001062993-22-020170.txt : 20221003
0001062993-22-020170.hdr.sgml : 20221003
20221003171925
ACCESSION NUMBER: 0001062993-22-020170
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220930
FILED AS OF DATE: 20221003
DATE AS OF CHANGE: 20221003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dentzer James E
CENTRAL INDEX KEY: 0001400977
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15911
FILM NUMBER: 221288615
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 6 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Imunon, Inc.
CENTRAL INDEX KEY: 0000749647
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521256615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 997 LENOX DRIVE
STREET 2: SUITE 100
CITY: LAWRENCEVILLE
STATE: NJ
ZIP: 08648
BUSINESS PHONE: (609) 896-9100
MAIL ADDRESS:
STREET 1: 997 LENOX DRIVE
STREET 2: SUITE 100
CITY: LAWRENCEVILLE
STATE: NJ
ZIP: 08648
FORMER COMPANY:
FORMER CONFORMED NAME: Celsion CORP
DATE OF NAME CHANGE: 20071121
FORMER COMPANY:
FORMER CONFORMED NAME: CELSION CORP
DATE OF NAME CHANGE: 19980515
FORMER COMPANY:
FORMER CONFORMED NAME: CHEUNG LABORATORIES INC
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-09-30
0000749647
Imunon, Inc.
IMNN
0001400977
Dentzer James E
C/O IMUNON, INC.
997 LENOX DRIVE, SUITE 100
LAWRENCEVILLE
NJ
08648
1
0
0
0
Option (right to buy)
1.68
2022-09-30
4
A
0
2667
0
A
2032-09-30
Common Stock
2667
2667
D
Represents an option grant under the Issuer's 2018 Stock Plan. The option vests in equal installments commencing January 1, 2023 and annually thereafter.
/s/ James Dentzer by Jeffrey Church, Attorney-in-fact
2022-10-03